Manufacturers focus on the manufacturing of generic sterile injectable drugs without any impact on their injectable quality. The development of generic sterile injectable products contributes to ...

which is bypassed in the development of generic injectables. Thus, the low cost associated with generic injectables is one of the major factors attracting new players to enter the market and ...

Global generic injectables market is forecast to expand impressively at a CAGR of 13.3% during the forecast period (2020-2025). Governments worldwide are encouraging distribution and development of ...

Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Generic ... of biosimilar injectables increase, providing a lower-cost alternative to expensive branded biologics. Moreover, technological innovations ...

Under the agreement, HKF will acquire the right, title and interest, to 18 additional generic injectable products within the U.S. HKF will be responsible for the ongoing development and ...

ProvideGx, a subsidiary of Premier, will collaborate with Fresenius Kabi to help mitigate national shortages of five generic injectable ... co-fund development of affordable products and secure ...

“Demand for cutting edge injectable capabilities should grow as antibody drug conjugates (ADCs) and other high-value products dominate the "potent compound" development space,"Sharma says. However, ...

Global medical technology company Baxter International Inc.BAX, to expand in the field of generic injectables, has formed a strategic partnership with Taiwan-based process R&D and active ...